These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Cutaneous leishmaniasis. Treatment with itraconazole. Albanese G, Giorgetti P, Santagostino L, Crippa D, Sala G. Arch Dermatol; 1989 Nov; 125(11):1540-2. PubMed ID: 2554818 [Abstract] [Full Text] [Related]
13. Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases. Costa JM, Marsden PD, Llanos-Cuentas EA, Netto EM, Carvalho EM, Barral A, Rosa AC, Cuba CC, Magalhães AV, Barreto AC. J Trop Med Hyg; 1986 Dec; 89(6):319-23. PubMed ID: 3806749 [Abstract] [Full Text] [Related]
15. Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives. Navarro M, Gabbiani C, Messori L, Gambino D. Drug Discov Today; 2010 Dec; 15(23-24):1070-8. PubMed ID: 20974285 [Abstract] [Full Text] [Related]
16. [Chemotherapy of leishmaniasis and human trypanosomiasis: status and new developments]. Kayser O, Croft SL, Kolodziej H. Pharm Unserer Zeit; 1999 Jul; 28(4):177-85. PubMed ID: 10443145 [No Abstract] [Full Text] [Related]
17. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis. Everlien H, Hockertz S. Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050 [Abstract] [Full Text] [Related]
18. Amphotericin B in visceral leishmaniasis. Jha BB. Indian Pediatr; 1996 Nov; 33(11):971. PubMed ID: 9141838 [No Abstract] [Full Text] [Related]